Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV000622919 | SCV000740745 | uncertain significance | Inborn genetic diseases | 2014-10-19 | criteria provided, single submitter | clinical testing | The c.6079A>G (p.K2027E) alteration is located in exon 34 (coding exon 34) of the NOTCH2 gene. This alteration results from a A to G substitution at nucleotide position 6079, causing the lysine (K) at amino acid position 2027 to be replaced by a glutamic acid (E). The alteration is not observed in healthy cohorts:_x000D_ Based on data from the NHLBI Exome Sequencing Project (ESP), the NOTCH2 c.6079A>G alteration was not observed among 6,497 individuals tested. Allele frequency data for this nucleotide position are not currently available from the 1000 Genomes Project and the alteration is not currently listed in the Database of Single Nucleotide Polymorphisms (dbSNP). Though some variants may appear to be rare due to database-specific ethnic underrepresentation, rare missense alleles commonly exhibit a deleterious effect on protein function (Kryukov, 2007; Tennessen, 2012). IF USED, PULL THESE INTO REFERENCES:_x000D_ Kryukov GV, et al. (2007) Am J Hum Genet 80:727-739. Tennessen JA, et al. (2012) Science 337(64):64-69. The altered nucleotide is conserved throughout evolution:_x000D_ The c.6079A nucleotide is well conserved in available vertebrate species, except the blowfish, stickleback, and the zebrafish._x000D_ _x000D_ The altered amino acid is conserved throughout evolution:_x000D_ The p.K2027 amino acid is completely conserved in available mammal species. The c.6079A>G (p.K2027E) alteration is located in coding exon 34 of the NOTCH2 gene. The alteration results from an A to G substitution at nucleotide position 6079, causing the Lysine (K) at amino acid position 2027 to be replaced by a Glutamic acid (E). The amino acid is located in a functionally important protein domain:_x000D_ The p.K2027E amino acid is located in the ankyrin repeat domain of the NOTCH2 protein. The ankyrin repeat domain is located in the intracellular part of the NOTCH2 protein and mediates protein-protein interactions. Pathogenic alterations in the ankyrin repeat domain are associated with Alagille syndrome and are predicted to affect the ability of the Notch intracellular domain to bind to other transcription factors (Penton, 2012). In silico prediction is conflicting:_x000D_ The p.K2027E alteration is predicted to be benign by Polyphen and deleterious by SIFT in silico analyses._x000D_ The alteration is predicted not to affect splicing by in silico models:_x000D_ Based on BDGP and ESEfinder splice site in silico tools, this alteration does not have any significant effect on the native acceptor/donor splice site; however, direct evidence is unavailable Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
| Fulgent Genetics, |
RCV002477363 | SCV002777095 | uncertain significance | Alagille syndrome due to a NOTCH2 point mutation; Hajdu-Cheney syndrome | 2022-03-02 | criteria provided, single submitter | clinical testing |